Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease

ALLAIX, Marco Ettore;
2013-01-01

2013
56
4
449
457
Inflammatory bowel disease; Infliximab; Laparoscopy; Morbidity; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Blood Loss, Surgical; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Laparoscopy; Length of Stay; Logistic Models; Male; Operative Time; Patient Readmission; Postoperative Complications; Reoperation; Retrospective Studies; Gastroenterology
Krane, Mukta K.; Allaix, Marco E.; Zoccali, Marco; Umanskiy, Konstantin; Rubin, Michele A.; Villa, Anthony; Hurst, Roger D.; Fichera, Alessandro...espandi
File in questo prodotto:
File Dimensione Formato  
2013_Preoperative Infliximab Therapy Does Not Increase.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 368.72 kB
Formato Adobe PDF
368.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1642781
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 63
  • ???jsp.display-item.citation.isi??? 59
social impact